Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

A population-based clinical trial comparing endocervical high-risk HPV testing using hybrid capture 2 and Cervista from the SHENCCAST II Study.

Belinson JL, Wu R, Belinson SE, Qu X, Yang B, Du H, Wu R, Wang C, Zhang L, Zhou Y, Liu Y, Pretorius RG.

Am J Clin Pathol. 2011 May;135(5):790-5. doi: 10.1309/AJCPKA6ATAPBZ6JQ.

2.

Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.

Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC)..

MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1-36.

3.

Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach.

Sizmann D, Glaubitz J, Simon CO, Goedel S, Buergisser P, Drogan D, Hesse M, Kröh M, Simmler P, Dewald M, Gilsdorf M, Fuerst M, Ineichen R, Kirn A, Pasche P, Wang Z, Weisshaar S, Young K, Haberhausen G, Babiel R.

J Clin Virol. 2010 Sep;49(1):41-6. doi: 10.1016/j.jcv.2010.06.004.

PMID:
20637687
4.

Validation of laboratory-developed molecular assays for infectious diseases.

Burd EM.

Clin Microbiol Rev. 2010 Jul;23(3):550-76. doi: 10.1128/CMR.00074-09. Review.

5.

Performance of the Aptima HIV-1 RNA qualitative assay with 16- and 32-member specimen pools.

Ethridge SF, Hart C, Hanson DL, Parker MM, Sullivan TJ, Bennett B, Stephens P, Hilliard J, Patel P.

J Clin Microbiol. 2010 Sep;48(9):3343-5. doi: 10.1128/JCM.01030-10.

6.

Multicenter evaluation of the LightCycler methicillin-resistant Staphylococcus aureus (MRSA) advanced test as a rapid method for detection of MRSA in nasal surveillance swabs.

Peterson LR, Liesenfeld O, Woods CW, Allen SD, Pombo D, Patel PA, Mehta MS, Nicholson B, Fuller D, Onderdonk A.

J Clin Microbiol. 2010 May;48(5):1661-6. doi: 10.1128/JCM.00003-10.

7.

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH; Society for Healthcare Epidemiology of America.; Infectious Diseases Society of America..

Infect Control Hosp Epidemiol. 2010 May;31(5):431-55. doi: 10.1086/651706.

PMID:
20307191
8.

Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C.

Poordad FF.

Aliment Pharmacol Ther. 2010 Jun;31(12):1251-67. doi: 10.1111/j.1365-2036.2010.04300.x. Review.

9.

Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.

De Bel A, Marissens D, Debaisieux L, Liesnard C, Van den Wijngaert S, Lauwers S, Piérard D.

J Clin Microbiol. 2010 Apr;48(4):1337-42. doi: 10.1128/JCM.01226-09.

10.

ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.

Kitchener HC, Almonte M, Gilham C, Dowie R, Stoykova B, Sargent A, Roberts C, Desai M, Peto J; ARTISTIC Trial Study Group..

Health Technol Assess. 2009 Nov;13(51):1-150, iii-iv. doi: 10.3310/hta13510.

11.

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD; International AIDS Society-USA..

Top HIV Med. 2008 Aug-Sep;16(3):266-85.

PMID:
19856548
12.
13.
15.

History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results.

Cox JT.

J Clin Virol. 2009 Jul;45 Suppl 1:S3-S12. doi: 10.1016/S1386-6532(09)70002-2. Review. Erratum in: J Clin Virol. 2010 Mar;47(3):299.

PMID:
19651367
16.

Prevalence and management of invalid GeneXpert enterovirus results obtained with cerebrospinal fluid samples: a 2-year study.

Sefers SE, Raymer AK, Kilby JT, Persing DH, Tang YW.

J Clin Microbiol. 2009 Sep;47(9):3008-10. doi: 10.1128/JCM.01238-09.

17.

Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections.

Mahony JB, Blackhouse G, Babwah J, Smieja M, Buracond S, Chong S, Ciccotelli W, O'Shea T, Alnakhli D, Griffiths-Turner M, Goeree R.

J Clin Microbiol. 2009 Sep;47(9):2812-7. doi: 10.1128/JCM.00556-09.

18.

Clostridium difficile strains from community-associated infections.

Limbago BM, Long CM, Thompson AD, Killgore GE, Hannett GE, Havill NL, Mickelson S, Lathrop S, Jones TF, Park MM, Harriman KH, Gould LH, McDonald LC, Angulo FJ.

J Clin Microbiol. 2009 Sep;47(9):3004-7. doi: 10.1128/JCM.00964-09.

19.

Recommended principles and practices for validating clinical molecular pathology tests.

Jennings L, Van Deerlin VM, Gulley ML; College of American Pathologists Molecular Pathology Resource Committee..

Arch Pathol Lab Med. 2009 May;133(5):743-55. doi: 10.1043/1543-2165-133.5.743. Review.

PMID:
19415949
20.

A review of human carcinogens--Part B: biological agents.

Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group..

Lancet Oncol. 2009 Apr;10(4):321-2. No abstract available.

PMID:
19350698
Items per page

Supplemental Content

Support Center